Table 4 Breast Cancer Total Cumulative Charges by Initial Treatment at Diagnosis and Charge Type
From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
Health care charges ($US) | Surgical Resection n=73 | Adjuvant n=553 | Neoadjuvant n=148 | Adjuvant vs. Neoadjuvant | |||
|---|---|---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | p-value | |
Breast Cancer related | |||||||
Facilities/ Technical | 23,472 (21,512) | 19,840 (28,345) | 27,486 (24,400) | 22,456 (32,113) | 35,877 (27,496) | 33,984 (38,937) | 0.00 |
Physician/ Professional | 12,942 (10,770) | 10,840 (12,678) | 15,575 (13,091) | 12,449 (17,812) | 17,340 (12,663) | 15,536 (16,820) | 0.04 |
Pharmacy | 19,702 (57,840) | 993 (2,650) | 37,000 (66,360) | 8,531 (51,815) | 64,705 (79,214) | 43,009 (83,327) | <0.0001 |
Total Anticancer Treatment | 11,491 (43,165) | 0 (0) | 21,564 (53,960) | 2,241 (13,526) | 40,941 (71,342) | 4,556 (57,935) | 0.00 |
Clinical Trial | 47 (196) | 0 (0) | 31 (215) | 0 (0) | 78 (297) | 0 (0) | 0.01 |
Chemotherapy | 3,604 (12,107) | 0 (0) | 7,204 (14,053) | 1,759 (6,352) | 7,376 (10,451) | 3,905 (9,278) | 0.01 |
Hormonal Therapy | 1,022 (5,843) | 0 (0) | 836 (5,814) | 0 (0) | 399 (2,711) | 0 (0) | 0.95 |
Biologic Medicine | 6,818 (36,636) | 0 (0) | 13,492 (46,279) | 0 (0) | 33,088 (66,386) | 0 (40,885) | <0.0001 |
Chemotherapy Administration | 2 (15) | 0 (0) | 0 (4) | 0 (0) | 0 (0) | 0 (0) | . |
Other Medication(s) | 8,210 (21,536) | 993 (2,559) | 15,436 (23,472) | 2,530 (24,473) | 23,764 (24,934) | 12,018 (42,041) | <0.0001 |